Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
about
Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implicationsBiomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityModulation of host adaptive immunity by hRSV proteinsRecent vaccine development for human metapneumovirusA novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent modelsStimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infectionRelationships between chronic obstructive pulmonary disease and lung cancer: biological insightsAntiviral activity of Nrf2 in a murine model of respiratory syncytial virus diseaseRespiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infectionImmunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in miceRespiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary glandInference of surface membrane factors of HIV-1 infection through functional interaction networks.Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte responseClinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer.Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease.The infectious march: the complex interaction between microbes and the immune system in asthma.Therapeutic targeting of respiratory syncytial virus G-protein.New immune pathways from chronic post-viral lung diseaseNanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination.IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection.Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and DiseaseRespiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB.Cell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and ageRNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.The host response and molecular pathogenesis associated with respiratory syncytial virus infection.Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection.Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine DesignRespiratory syncytial virus: current progress in vaccine development.Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus InfectionsNew Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection.Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication.Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15).
P2860
Q26991548-12D84E07-1F46-4379-B869-61D15B670329Q27010165-05D97380-31C7-47DA-B99E-D12B5D441397Q27022693-E4366D39-52DF-40CE-9751-E632A2FFB2F3Q27023742-DBF46B02-15DC-4DD5-9EF4-DC725C2E1F9EQ27312129-E582FBBA-DF42-49B3-BE3A-96FE1A7E2544Q27334724-2C30A268-34CF-4FB2-9BFA-F3679D89019DQ28077681-D7FABC0A-5284-45E0-805F-2A16907EEEA6Q28387231-53EF4B2F-E01D-4D12-A43A-16502E021A8DQ28481271-5FC51AD4-29B9-411E-94A3-E2FC48C091B9Q28730052-9A0596CD-2CFB-4331-B170-2DFB19E23A47Q30412460-E95B348F-916D-41BB-A1E2-EBE0978ECEFCQ33578748-679FE074-00A6-4B10-9738-990B9D3414B7Q33610623-1F77958C-104F-44E7-B16D-A57A5F634F93Q33725721-28CD7CBC-F1D8-4123-8762-83824C206C0CQ33886159-D742A565-51BC-47C7-88DE-FFAE49AF4100Q34141885-CEFD6B17-30C1-4C3F-9FFE-4677B47151BBQ34202091-269534D8-E455-447D-870C-12EE0A1D5E12Q34262180-ADA4D905-8ADF-4F38-B2EC-7DB0495939D0Q34336540-7BD84C21-3D47-4F15-8C18-940767EE54E2Q34356430-3FC068BE-79D6-4C40-89D6-BF210BA38F9FQ34603346-301FF204-CB02-43E8-BBB0-7958B06B739CQ34692122-366B9F46-D56A-42FC-818A-55612AE46B94Q34990420-574B5341-D341-4BB3-8684-CD4FDD03DA09Q35887649-12FA619A-38ED-4CB0-9322-F029F91A0386Q36262581-E5DAF616-0D61-4AC5-B7F3-23AE7E23D7F8Q36363236-87CF8099-E9F7-4D91-86A7-AF221F904A16Q36409517-809B7514-A7BB-41DE-95D3-522C3EFD3226Q36486630-8CFC1939-C896-4678-86BC-FE0DBB1876D6Q36977881-0FA0B25C-D056-49F1-96A9-CDAB6106AEBAQ36994716-B6A0CE2C-3399-4FE9-8B8B-887427E55534Q37051620-6AA4EC80-D5AF-47B7-9B80-8B662D59AECAQ37263779-E7EDB253-3736-4356-AD83-C2C3596FB17FQ37713845-FD79C9C5-BAEC-4D34-BE0C-DCE07B0C187DQ37729137-F035258E-46C9-4793-AC63-F7EA1D37CD4AQ38079432-D2353B3D-631A-4861-A5E1-9131DCB9C0BBQ38163544-80974A2C-8131-4D6D-A946-01DA282FB54EQ38628928-4B2B63E2-A597-4BD2-9078-EEF0C713640BQ38752668-75E9B881-4C9D-45F8-A6AF-6E60983E50F0Q39297218-264C56E3-F914-4BE6-A754-169248913580Q39929993-4B40E11B-3273-4A2D-B84C-B08BD153C871
P2860
Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Respiratory syncytial virus (R ...... markers of allergy--a review.
@ast
Respiratory syncytial virus (R ...... markers of allergy--a review.
@en
type
label
Respiratory syncytial virus (R ...... markers of allergy--a review.
@ast
Respiratory syncytial virus (R ...... markers of allergy--a review.
@en
prefLabel
Respiratory syncytial virus (R ...... markers of allergy--a review.
@ast
Respiratory syncytial virus (R ...... markers of allergy--a review.
@en
P1433
P1476
Respiratory syncytial virus (R ...... markers of allergy--a review.
@en
P2093
Yechiel Becker
P2860
P2888
P304
P356
10.1007/S11262-006-0064-X
P577
2006-10-01T00:00:00Z